项目1：脑类固醇受体共激活剂和能量稳态-猫眼课题宝

项目1：脑类固醇受体共激活剂和能量稳态

批准号：

10421282

负责人：

YONG XU

金额：

$31.7万

依托单位：

BAYLOR COLLEGE OF MEDICINE

依托单位国家：

美国

项目类别：

财政年份：

2018

资助国家：

美国

项目状态：

已结题

起止时间：

2018-07-01 至 2024-04-30

来源：

https://reporter.nih.gov/project-details/10421282

关键词：

Ablation Adipose tissue Age of Onset Animal Model Anorexia Attenuated Biochemical Body Weight Body mass index Brain Brain region CRISPR/Cas technology Characteristics Child Chronic Clustered Regularly Interspaced Short Palindromic Repeats Code Complex Cues Cultured Cells DNA Sequence Alteration Development Diet Dissociation Eating Energy Intake Energy Metabolism Ensure Equilibrium Estrogen Receptor alpha FOXO1A gene Fasting Fatty acid glycerol esters Feeding behaviors Genes Genetic Transcription Glucose High Fat Diet Homeostasis Hour Human Hyperphagia Hypothalamic structure Impairment Individual Insulin Knock-in Mouse Leptin Liver Locomotion Mediating Mediator of activation protein Metabolic Metabolism Modeling Molecular Mus Mutant Strains Mice Mutation Neurons Nuclear Receptors Nutritional Obesity PPAR gamma Pathway interactions Peripheral Phase Property Proteins Regimen Reservations Role Signal Transduction Signaling Molecule Stat3 protein Steroid Receptors System Technology Testing Thyroid Hormone Receptor Time Tissues Universities Weight Gain cohort diet-induced obesity energy balance exhibitions feeding insulin sensitivity metabolic phenotype mind control mouse model mutant new therapeutic target novel novel therapeutics nuclear receptor coactivator 1 obesity prevention obesity treatment overexpression prevent programs response severe early onset obesity transcription factor transcriptome

项目摘要

项目成果

YONG XU的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Project 1 - Project Summary Numerous nuclear receptors (NRs) or transcription factors (TFs) have been identified as important regulators of body weight. However, anti-obesity regimens targeting these individual molecules alone are far from satisfying. Coactivators interact with a broad range of NRs/TFs and may serve as master regulators that coordinate and synergize actions of multiple metabolic signals. High levels of Steroid Receptor Coactivator-1 and -2 (SRC-1 and SRC-2) are expressed in the hypothalamus, the key brain region controlling feeding and body weight balance. The pilot observations led to a hypothesis that hypothalamic SRC-1 and SRC-2 coactivate STAT3 and FoxO1, repectively, to provide coordinated control of energy metabolism. Aim 1 will determine whether hypothalamic SRC-1 fine-tunes STAT3 transcription activity to mediate the anti-obesity effects of leptin. Mouse models lacking or overexpressing SRC-1 only in leptin-responsive neurons have been generated. Metabolic parameters in response to different diets or to leptin treatment will be assessed in these mice. Importantly, the molecular mechanisms by which the SRC1-pSTAT3 complex regulates leptin signaling will be delineated. Aim 2 will determine whether human SRC-1 mutations impair leptin-STAT3 pathway in the hypothalamus and cause obesity. Using the CRISPR technology, a knockin mouse line has been generated to mimic a SRC-1 genetic mutation associated with human obesity. Metabolic phenotypes of these mice will be characterized, and leptin- STAT3 actions and STAT3 transcription activity will be evaluated. Aim 3 will determine whether hypothalamic SRC-2 coativates FoxO1 transcriptional activity to facilitate energy reservations. Mice lacking or overexpressing SRC-2 in mature POMC neurons have been generated, with/without FoxO1 overexpression. Metabolic phenotypes will be characterized in all these models and FoxO1 transcriptional activity will also be evaluated.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文